GLP Watchdog

Mochi Health vs SkinnyRx

SkinnyRx has an open FDA warning letter dated February 20, 2026. Mochi Health has none. On Foundayo (orforglipron) pill, Mochi Health costs $1,656 less a year at standing rates: $110 a month against $248 a month at SkinnyRx.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Mochi Health / SkinnyRx

Mochi Health logo

Mochi Health

7.1/10

Featured pick (affiliate partner)

SkinnyRx logo

SkinnyRx

6.3/10

FDA warning letters
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$110/moFoundayo (orforglipron) pill
$248/moBrand-name semaglutide pill
States
All 50 states
47 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Mochi Health
Visit SkinnyRx

SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Mochi Health pays us nothing. The scores are computed the same way for both and are shown as computed (Mochi Health 7.1, SkinnyRx 6.3). How we are paid

What the record shows

  1. 01

    SkinnyRx has an open FDA warning letter dated February 20, 2026. Mochi Health has none.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    On Foundayo (orforglipron) pill, Mochi Health costs $1,656 less a year at standing rates: $110 a month against $248 a month at SkinnyRx.

  4. 04

    Only SkinnyRx lists a price for compounded oral tirzepatide.

  5. 05

    Mochi Health covers three states SkinnyRx does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Mochi Health

SkinnyRx

Compounded semaglutide injection

$139/mo

plan terms unclear; not compared

$99/mo

first month only; not compared

Compounded tirzepatide injection

$169/mo

plan terms unclear; not compared

$99/mo

first month only; not compared

Brand-name semaglutide pen

$199/mo

medication only, membership extra; not compared

$1,400/mo

$16,800 a year

Brand-name tirzepatide pen

$299/mo

medication only, membership extra; not compared

$1,400/mo

$16,800 a year

Compounded oral semaglutide

$141/mo

$1,692 a year

$149/mo

first month only; not compared

Brand-name semaglutide pill

$149/mo

medication only, membership extra; not compared

$248/mo

$2,976 a year

Foundayo (orforglipron) pill

$110/moLower

$1,320 a year

$248/mo

$2,976 a year

Compounded oral tirzepatide
Not sold or not priced

$199/mo

first month only; not compared

Price includes
Clinician visits, coaching
Medication, clinician visits, shipping
Billed separately
Medication
Not stated
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month memberships are prepaid
None stated; subscriptions auto-renew until canceled at least 5 days before the renewal date
Refunds
No refunds for partly used periods; medication is not refundable once sent to the pharmacy
Full refund before a provider completes the prescription review; no refunds for partially used subscription periods

Read off each seller’s own pages. Mochi Health: October 31, 2026. SkinnyRx: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Mochi Health

7.1/10
  • No FDA warning letter on record
  • $1,656 a year less on Foundayo (orforglipron) pill
  • Names no compounding pharmacy
  • Price leaves out medication
Visit Mochi Health

The case for SkinnyRx

6.3/10
Featured pick (affiliate partner)
  • Sells compounded oral tirzepatide, which Mochi Health does not price
  • Open FDA warning letter, February 20, 2026
  • Names no compounding pharmacy
Visit SkinnyRx

Scores

Mochi Health 7.1 · SkinnyRx 6.3 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
5.6

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

7.5A
vs
B
3.0

Trust & Safety15%

8.5A
vs
B
2.0

Accessibility10%

10.0A
vs
B
9.5

Support10%

4.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Mochi Health vs SkinnyRx: questions

SkinnyRx has an open FDA warning letter dated February 20, 2026. Mochi Health has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Mochi Health, by $1,656 a year at standing rates. Mochi Health: $110 a month, about $1,320 a year. SkinnyRx: $248 a month, about $2,976 a year.
Mochi Health states you can cancel at any time; refunds: no refunds for partly used periods; medication is not refundable once sent to the pharmacy. SkinnyRx states you can cancel at any time; refunds: full refund before a provider completes the prescription review; no refunds for partially used subscription periods.
SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Mochi Health pays us nothing. The scores are computed the same way for both and are shown as computed (Mochi Health 7.1, SkinnyRx 6.3).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks